BIOMAT Database Logo BIOMAT Database Logo

Acute myocardial infarction during treatment with an activated prothrombin complex concentrate in a patient with factor VIII deficiency and a factor VIII inhibitor. 1988

S I Chavin, and D M Siegel, and T A Rocco, and J P Olson
Department of Medicine, Rochester General Hospital, New York 14621.

UI MeSH Term Description Entries
D008297 Male Males
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D001779 Blood Coagulation Factors Endogenous substances, usually proteins, that are involved in the blood coagulation process. Clotting Factor,Coagulation Factors,Blood Coagulation Factor,Clotting Factors,Coagulation Factor,Coagulation Factor, Blood,Coagulation Factors, Blood,Factor, Coagulation,Factors, Coagulation,Factor, Blood Coagulation,Factor, Clotting,Factors, Blood Coagulation,Factors, Clotting
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D006467 Hemophilia A The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage. Factor VIII Deficiency,Hemophilia,Autosomal Hemophilia A,Classic Hemophilia,Deficiency, Factor VIII,Factor 8 Deficiency, Congenital,Factor VIII Deficiency, Congenital,Haemophilia,Hemophilia A, Congenital,Hemophilia, Classic,As, Autosomal Hemophilia,Autosomal Hemophilia As,Classic Hemophilias,Congenital Hemophilia A,Congenital Hemophilia As,Hemophilia A, Autosomal,Hemophilia As,Hemophilia As, Autosomal,Hemophilia As, Congenital,Hemophilias, Classic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

S I Chavin, and D M Siegel, and T A Rocco, and J P Olson
Use of activated prothrombin complex concentrate in a severely hemophilic patient with Factor VIII inhibitor.
April 1983, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons,
S I Chavin, and D M Siegel, and T A Rocco, and J P Olson
Acute myocardial infarction complicating prothrombin complex concentrate therapy in an 8-year-old boy with hemophilia A and factor VIII inhibitor.
November 1993, The American journal of pediatric hematology/oncology,
S I Chavin, and D M Siegel, and T A Rocco, and J P Olson
Myocardial infarction complicating activated prothrombin complex concentrate substitution in patient with hemophilia A.
November 1982, Lancet (London, England),
S I Chavin, and D M Siegel, and T A Rocco, and J P Olson
Inhibitor to factor IX following activated prothrombin-complex concentrate treatment.
February 1981, Thrombosis and haemostasis,
S I Chavin, and D M Siegel, and T A Rocco, and J P Olson
Pulmonary embolism after sequential use of recombinant factor VIIa and activated prothrombin complex concentrate in a factor VIII inhibitor patient.
May 2002, Thrombosis and haemostasis,
S I Chavin, and D M Siegel, and T A Rocco, and J P Olson
Effect of treatment with activated prothrombin complex concentrate (FEIBA) on factor VIII-antibody level.
February 1979, Thrombosis and haemostasis,
S I Chavin, and D M Siegel, and T A Rocco, and J P Olson
Acute myocardial infarction during substitution with recombinant factor VIII concentrate in a patient with mild haemophilia A.
August 2004, Thrombosis and haemostasis,
S I Chavin, and D M Siegel, and T A Rocco, and J P Olson
Successful self-infusion of activated prothrombin complex concentrate for prophylaxis in a child with a factor VIII inhibitor.
February 2007, American journal of hematology,
S I Chavin, and D M Siegel, and T A Rocco, and J P Olson
Successful treatment with prothrombin complex concentrate of postoperative bleeding in a haemophiliac with a factor VIII inhibitor.
November 1976, British medical journal,
S I Chavin, and D M Siegel, and T A Rocco, and J P Olson
Letter: Treatment of inhibitors to factor VIII with activated prothrombin concentrate.
November 1974, The New England journal of medicine,
Copied contents to your clipboard!